LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history

Annals of Surgical Oncology

Volumn 19, Issue 13, 2012, Pages 4238-4243

  Shigaki, Hironobu ^a   Baba, Yoshifumi ^a   Watanabe, Masayuki ^a   Iwagami, Shiro ^a   Miyake, Keisuke ^a   Ishimoto, Takatsugu ^a   Iwatsuki, Masaaki ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; CANCER PATIENT; CONTROLLED STUDY; DNA METHYLATION; DRINKING BEHAVIOR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENETIC CORRELATION; HISTOLOGY; HUMAN; LONG INTERSPERSED REPEAT; MAJOR CLINICAL STUDY; MALE; PYROSEQUENCING; SMOKING; TOBACCO DEPENDENCE;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA; DNA METHYLATION; EPIGENOMICS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTORS; SMOKING;

EID: 84876458283     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2488-y     Document Type: Article

References (33)

1. Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med. 2011;17:330-9.
2. Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin. 2011;60: 376-92.
3. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007; 128:683-92. (Pubitemid 46273572)
4. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2011;28:1057-68.
5. Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin. 2010;60:376-92.
6. Gaudet F, Hodgson JG, Eden A, et al. Induction of tumors in mice by genomic hypomethylation. Science. 2003;300:489-92. (Pubitemid 36444330)
7. Holm TM, Jackson-Grusby L, Brambrink T, et al. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell. 2005;8:275-85. (Pubitemid 41443413)
8. Suzuki K, Suzuki I, Leodolter A, et al. Global DNA demethyl-ation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell. 2006;9:199-207. (Pubitemid 43357946)
9. Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet. 2009;10:691-703.
10. Ogino S, Kawasaki T, Nosho K, et al. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer. 2008;122:2767-73. (Pubitemid 351631379)
11. Irahara N, Nosho K, Baba Y, et al. Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. J Mol Diagn. 2010; 12:177-83.
12. Ahn JB, Chung WB, Maeda O, et al. DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer. 2011;117:1847-54.
13. Zhang FF, Cardarelli R, Carroll J, et al. Significant differences in global genomic DNA methylation by genDer and race/ethnicity in peripheral blood. Epigenetics. 2011;6:623-9.
14. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003; 349:2241-52. (Pubitemid 37485141)
15. Tanaka F, Yamamoto K, Suzuki S, et al. Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut. 2010;59:1457-64.
16. Steevens J, Schouten LJ, Goldbohm RA, et al. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59: 39-48.
17. Morita M, Kumashiro R, Kubo N, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol. 2010;15:126-34.
18. Yokoyama A, Kumagai Y, Yokoyama T, et al. Health risk appraisal models for mass screening for esophageal and pharyngeal cancer: an endoscopic follow-up study of cancer-free Japanese men. Cancer Epidemiol Biomarkers Prev. 2009;18:651-5.
19. Yokoyama A, Omori T, Yokoyama T, et al. Risk of squamous cell carcinoma of the upper aerodigestive tract in cancer-free alcoholic Japanese men: an endoscopic follow-up study. Cancer Epidemiol Biomarkers Prev. 2006;15:2209-15. (Pubitemid 44883052)
20. Ishii T, Murakami J, Notohara K, et al. Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa. Gut. 2007;56:13-9. (Pubitemid 46044883)
21. Ushijima T. Epigenetic field for cancerization. J Biochem Mol Biol. 2007;40:142-50. (Pubitemid 46515191)
22. Wu DL, Sui FY, Jiang XM, et al. Methylation in esophageal carcinogenesis. World J Gastroenterol. 2006;12:6933-40.
23. Oka D, Yamashita S, Tomioka T, et al. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer. 2009;115:3412-26.
24. Ogino S, Nosho K, Kirkner GJ, et al. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst. 2008;100:1734-8.
25. Baba Y, Huttenhower C, Nosho K, et al. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer. 2010;9:125.
26. Baba Y, Nosho K, Shima K, et al. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastroenterology. 2010;139: 1855-64.
27. Iwagami S, Baba Y, Watanabe M, et al. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma. Ann Surg Oncol. 2011. doi:10.1245/s10434-011-2176-3.
28. Ogino S, Chan AT, Fuchs CS, et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisci-plinary and interdisciplinary field. Gut. 2011;60:397-411.
29. Schernhammer ES, Giovannucci E, Kawasaki T, et al. Dietary folate, alcohol and B vitamins in relation to LINE-1 hypome-thylation in colon cancer. Gut. 2010;59:794-9.
30. Sepulveda AR, Jones D, Ogino S, et al. CpG methylation analysis-current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology. J Mol Diagn. 2009;11:266-78.
31. Hsiung DT, Marsit CJ, Houseman EA, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2007;16:108-14. (Pubitemid 46174272)
32. Hou L, Wang H, Sartori S, et al. Blood leukocyte DNA hy-pomethylation and gastric cancer risk in a high-risk Polish population. Int J Cancer. 2010;127:1866-74.
33. Lee YC, Wang HP, Wang CP, et al. Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers. Cancer Prev Res (Phila). 2011;4:1982-92.